Cartesian Therapeutics, Inc. (RNAC)
6.72
-0.16
(-2.33%)
USD |
NASDAQ |
Dec 08, 16:00
7.03
+0.31
(+4.61%)
After-Hours: 20:00
Cartesian Therapeutics Shareholders Equity (Quarterly): -35.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp. | 2.083B |
| Cabaletta Bio, Inc. | 139.47M |
| Arcellx, Inc. | 440.78M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.68M |
| Total Liabilities (Quarterly) | 408.52M |
| Debt to Equity Ratio | -0.3516 |
| Current Ratio | 10.67 |
| Net Debt Paydown Yield | -0.16% |